SEATTLE – The Bill & Melinda Gates Foundation has picked an executive with pharmaceutical company Novartis Pharma AG to be president of its global health program.
The foundation said Tuesday that Dr. Trevor Mundel starts his new job Dec. 1. He succeeds Tadataka “Tachi” Yamada, who left the foundation in June after five years as head of the global health program.
Get weekly money news
In a statement, foundation CEO Jeff Raikes said Mundel’s “deep understanding of the complexities, challenges and opportunities to improve global health made him a prime match” for the post.
- Mixed reaction to City of Edmonton’s proposed 2027-2030 budgets
- De Havilland getting up to $2.5B in federal financing to ramp up water bomber production
- Stock markets shaky ahead of U.S. midterm election as Apple faces pressure
- City of Edmonton unveils proposed 4-year budget with higher taxes — but more services
Mundel will lead the foundation’s efforts to develop and deliver drugs, vaccines and other tools to fight developing world diseases.
He has been a senior executive and scientist with Novartis since 2003, serving most recently as global head of development.
Comments
Want to discuss? Please read our Commenting Policy first.